Studies of Molecular Mechanisms Underlying Cardioprotective Action of the ALM-802 Compound

[1]  Сергей Александрович Крыжановский,et al.  A translational model of chronic heart failure in rats , 2018, ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia».

[2]  C. Maack,et al.  Metabolic remodelling in heart failure , 2018, Nature Reviews Cardiology.

[3]  B. Hill,et al.  Metabolic Coordination of Physiological and Pathological Cardiac Remodeling , 2018, Circulation research.

[4]  C. Lang,et al.  Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure , 2017, Diseases.

[5]  I. Efimov,et al.  Arrhythmogenic and metabolic remodelling of failing human heart , 2016, The Journal of physiology.

[6]  P. Ponikowski,et al.  Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. , 2016, International journal of cardiology.

[7]  Andrew D. McCulloch,et al.  Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches , 2014, Front. Pharmacol..

[8]  K. Fukunaga,et al.  Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes. , 2013, American journal of physiology. Heart and circulatory physiology.

[9]  I. Komuro,et al.  Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy , 2011, Hypertension.

[10]  K. Mikoshiba,et al.  The IP3 Receptor Regulates Cardiac Hypertrophy in Response to Select Stimuli , 2010, Circulation research.

[11]  F. Lezoualc’h,et al.  The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes , 2007, The Journal of physiology.

[12]  Huan Wang,et al.  Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. , 2007, The Journal of biological chemistry.

[13]  Ali Ahmed,et al.  Myocardial beta‐1 adrenoceptor down‐regulation in aging and heart failure: implications for beta‐blocker use in older adults with heart failure , 2003, European journal of heart failure.